Literature DB >> 10553805

Altered contractile response of penis under hypoxia with metabolic acidosis.

D G Moon1, D S Lee, J J Kim.   

Abstract

Previous studies concerning ischemic priapism revealed that hypoxia alters the erectile and contractile responses of penis. But the effects of accompanying acidosis on those responses have not been fully evaluated or understood yet. We performed this study to elucidate the role of acidosis on the trabecular smooth muscle contractility like in ischemic priapism. Under the general anesthesia, 55 mature male cats were conditioned to systemic metabolic acidosis by hypoventilation by animal ventilator. The changes of intracavernous pressure (ICP) to erectogenic agents (acetylcholine, L-arginine, prostaglandin E1: PGE1), erectolytic agents (epinephrine, thromboxane A2; TXA2), K channel-related drugs (pinacidil, 4-aminopyridine, tetraethylammonium; TEA, glibenclamide) and calcium ionophore were monitored at Set 1 (PO2 > 60 mmHg, pH > 7.25), Set 2 (PO2 < 30 mmHg, 7.25 > pH > 7.0), Set 3 (PO2 < 30 mmHg, pH < 7.0), and Set 4 (PO2 > 60 mmHg, pH < 7.0) in vivo. At Set 1 and Set 2, epinephrine, TXA2, and ionomycin decreased the ICP by acetylcholine or PGE1 (n = 9, P < 0.01). The decrease of ICP was in order of epinephrine, TXA2 and ionomycin. Acidosis reduced the increase of ICP to acetylcholine or PGE1 (n = 8, P < 0.01), TXA2 or ionomycin did not affect ICP under severe acidosis but epinephrine decreased ICP even under severe acidosis (n = 7, P < 0.05). Pretreatment of potassium channel blockers did not suppress the increase of ICP by erectogenic agents under acidosis (n = 6, P < 0.05). Pinacidil did not affect ICP under acidosis (n = 6, P < 0.01). These results suggest that acidosis impairs the contractile response of cavernous smooth muscle to erectolytic agents. It may be the results of the interference by [H+] with the intra and extracellular mechanisms that regulate the homeostasis of [Ca2]. Conclusively, besides hypoxia, acidosis is another limiting factor of trabecular smooth muscle contractility like in ischemic priapism.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10553805     DOI: 10.1038/sj.ijir.3900433

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  6 in total

1.  Diagnostic and therapeutic options for the management of ischemic and nonischemic priapism.

Authors:  Jeffrey Bassett; Jacob Rajfer
Journal:  Rev Urol       Date:  2010

Review 2.  Management of priapism: an update for clinicians.

Authors:  Helen R Levey; Robert L Segal; Trinity J Bivalacqua
Journal:  Ther Adv Urol       Date:  2014-12

Review 3.  Priapism: pathophysiology and the role of the radiologist.

Authors:  J E Halls; D V Patel; M Walkden; U Patel
Journal:  Br J Radiol       Date:  2012-09-06       Impact factor: 3.039

Review 4.  Management of refractory ischemic priapism: current perspectives.

Authors:  Marco Capece; Arianna Gillo; Andrea Cocci; Giulio Garaffa; Massimiliano Timpano; Marco Falcone
Journal:  Res Rep Urol       Date:  2017-08-29

5.  Ischemic priapism as a model of exhausted metabolism.

Authors:  Sanne Vreugdenhil; Pedro J Freire Jorge; Mels F van Driel; Maarten W Nijsten
Journal:  Physiol Rep       Date:  2019-03

Review 6.  Recent advances in the management of priapism.

Authors:  Asif Muneer; Hussain M Alnajjar; David Ralph
Journal:  F1000Res       Date:  2018-01-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.